* Eikon search string for individual stock moves: STXBZ
* The Day Ahead newsletter: http://tmsnrt.rs/2ggOmBi
* The Morning News Call newsletter: http://tmsnrt.rs/2fwPLTh
Futures tracking the S&P 500 were little changed on Thursday as U.S. coronavirus
infections surged and investors weighed the timeline of the roll-out of an
effective vaccine, while technology stocks headed higher for the second straight
day. .N
At 7:03 ET, Dow e-minis 1YMc1 were down 0.39% at 29,198. S&P 500 e-minis
ESc1 were down 0.08% at 3,565.25, while Nasdaq 100 e-minis NQc1 were up
0.43% at 11,937.5.
The top three NYSE percentage gainers premarket .PRPG.NQ :
** Babcock & Wilcox BW.N , up 21.3%
** J.Jill Inc JILL.N , up 18.4%
** Braemar Hotels BHR.N , up 14.5%
The top three NYSE percentage losers premarket .PRPL.NQ :
** Just Energy JE.N , down 10.7%
** Revolve Group RVLV.N , down 10%
** CorEnergy CORR.N , down 9.9%
The top three Nasdaq percentage gainers premarket .PRPG.O :
** IMAC Holdings IMACW.O , up 193.0%
** EuroDry EDRY.O , up 143.0%
** IMAC Holdings Inc IMAC.O , up 86.1%
The top three Nasdaq percentage losers premarket .PRPL.O :
** Rave Restaurant RAVE.O , down 11.8%
** Vroom Inc VRM.O , down 11.5%
** SpartanNash Co SPTN.O , down 10.4%
** Fossil FOSL.O : up 27.3% premarket
BUZZ-Fossil swings to qtrly profit on strong China growth urn:newsml:reuters.com:*:nL4N2HX4K0
** Sundial Growers SNDL.O : down 8.2% premarket
BUZZ-Slides on underwhelming third-quarter revenue urn:newsml:reuters.com:*:nL4N2HX4JR
** Nike NKE.N : up 0.1% premarket
BUZZ-RBC says well-positioned to emerge from virus-led disruptions, starts
coverage urn:newsml:reuters.com:*:nL4N2HY2LL
** Qiagen QGEN.N : up 1.5% premarket
BUZZ-Qiagen U.S. shares up on launch of portable COVID-19 antigen test
urn:newsml:reuters.com:*:nL4N2HX4IE
** Xpeng Inc XPEV.N : up 11.3% premarket
BUZZ-Surges on Q3 revenue beat, strong outlook urn:newsml:reuters.com:*:nL4N2HY32F
** Pinduoduo PDD.O : up 23.1% premarket
BUZZ-Jumps on third-quarter revenue beat urn:newsml:reuters.com:*:nL4N2HY30G
** CureVac CVAC.O : up 4.7% premarket
BUZZ-Up after CEO eyes approval of COVID-19 vaccine in Q3 2021 urn:newsml:reuters.com:*:nL4N2HY3E0
(Compiled by Shreyasee Raj in Bengaluru)
((Shreyasee.Raj@thomsonreuters.com;))